[go: up one dir, main page]

AU5397496A - Low dose ridogrel formulations and their use for the treatme nt of inflammatory bowel diseases - Google Patents

Low dose ridogrel formulations and their use for the treatme nt of inflammatory bowel diseases

Info

Publication number
AU5397496A
AU5397496A AU53974/96A AU5397496A AU5397496A AU 5397496 A AU5397496 A AU 5397496A AU 53974/96 A AU53974/96 A AU 53974/96A AU 5397496 A AU5397496 A AU 5397496A AU 5397496 A AU5397496 A AU 5397496A
Authority
AU
Australia
Prior art keywords
treatme
ridogrel
formulations
inflammatory bowel
low dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53974/96A
Inventor
Maria-Helena Joris Jozef Verlinden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of AU5397496A publication Critical patent/AU5397496A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU53974/96A 1995-03-28 1996-03-18 Low dose ridogrel formulations and their use for the treatme nt of inflammatory bowel diseases Abandoned AU5397496A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95200768 1995-03-28
EP95200768 1995-03-28
PCT/EP1996/001229 WO1996030016A2 (en) 1995-03-28 1996-03-18 Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases

Publications (1)

Publication Number Publication Date
AU5397496A true AU5397496A (en) 1996-10-16

Family

ID=8220134

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53974/96A Abandoned AU5397496A (en) 1995-03-28 1996-03-18 Low dose ridogrel formulations and their use for the treatme nt of inflammatory bowel diseases

Country Status (10)

Country Link
EP (1) EP0817631A2 (en)
JP (1) JPH10511097A (en)
AR (1) AR002727A1 (en)
AU (1) AU5397496A (en)
CA (1) CA2215160A1 (en)
HU (1) HUP9900309A3 (en)
IL (1) IL117670A (en)
NO (1) NO974486L (en)
WO (1) WO1996030016A2 (en)
ZA (1) ZA962461B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9620709D0 (en) * 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
WO2002072069A1 (en) * 2001-03-12 2002-09-19 Novo Nordisk A/S Novel tablets and capsules and a process for its preparation
ITRM20050389A1 (en) 2005-07-22 2007-01-23 Giuliani Spa COMPOUNDS AND THEIR SPECIFIC SALTS FOR PPAR RECEPTORS AND RECEPTORS FOR EGF AND THEIR USE IN MEDICAL FIELDS.
UA107562C2 (en) 2008-12-05 2015-01-26 METHOD OF TREATMENT OF PSORIASIS
WO2010091892A2 (en) 2009-02-16 2010-08-19 Giuliani International Limited Alkylamido compounds and uses thereof
US9682923B2 (en) 2012-02-09 2017-06-20 Nogra Pharma Limited Methods of treating fibrosis
BR112014026160A2 (en) 2012-04-18 2017-07-18 Nogra Pharma Ltd Methods To Treat Lactose Intolerance
WO2017046343A1 (en) * 2015-09-17 2017-03-23 Nogra Pharma Limited Compositions for rectal administration in the treatment of ulcerative colitis and methods of using same
EP3921299B1 (en) 2019-02-08 2024-11-20 Nogra Pharma Limited Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746671A (en) * 1985-11-04 1988-05-24 Janssen Pharmaceutica N.V. Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters

Also Published As

Publication number Publication date
WO1996030016A3 (en) 1997-01-30
HUP9900309A2 (en) 1999-05-28
WO1996030016A2 (en) 1996-10-03
IL117670A0 (en) 1996-07-23
IL117670A (en) 2000-02-29
NO974486D0 (en) 1997-09-29
AR002727A1 (en) 1998-04-29
ZA962461B (en) 1997-09-29
NO974486L (en) 1997-09-29
JPH10511097A (en) 1998-10-27
EP0817631A2 (en) 1998-01-14
HUP9900309A3 (en) 1999-11-29
MX9707394A (en) 1997-11-29
CA2215160A1 (en) 1996-10-03

Similar Documents

Publication Publication Date Title
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
AU3696889A (en) Anti-inflammatory and antimicrobial formulations for dermatologic and inflammatory diseases
AU5355094A (en) Therapeutic and diagnostic imaging compositions and methods
AU3265695A (en) Novel naphthyridine derivative and medicinal composition thereof
AU7578696A (en) Morpholine derivatives and their use as therapeutic agents
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
AU2995892A (en) Physiological tear compositions and methods for their preparation
AU5315898A (en) Compositions for disinfection of skin and mucous membrane
AU2027595A (en) Pharmaceutical composition for treating inflammatory bowel diseases
AU6590896A (en) Pharmaceutical compositions containing tsg-6 for treating inflammatory diseases and cancer-related pathologies and methods
AU6856094A (en) Oxadiazole derivative and medicinal composition thereof
AU6858996A (en) Pharmaceutical compositions for the treatment of infectious diseases
AU2753095A (en) Triterpene derivative and medicinal composition
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU2886292A (en) Compositions and methods for treatment of epstein-barr virus-associated diseases
AU5397496A (en) Low dose ridogrel formulations and their use for the treatme nt of inflammatory bowel diseases
AU1847695A (en) Pharmaceutical formulations of cntf
AU6837096A (en) 2-acylaminobenzamide derivatives and preventive and remedy for diseases caused by the supermultiplication of vascular intimal cells
PL327168A1 (en) Pharmaceutical compositions suitable for use in treatment of diseases associated with venal lesions and/or inflammatore oedema and novel compounds used in such compositions
AU2587195A (en) Growth hormone therapy and related methods and pharmaceutical compositions
HUP9800829A3 (en) Collagen-based methods and formulations for the treatment of immune system-mediated diseases
EP0747351A3 (en) Thiocationic lipids, pharmaceutical compositions and methods of use thereof
AU6961298A (en) Therapeutic compositions and diagnostic assays for diseases involving trbp
AU6381496A (en) Therapeutic inhibition of phospholipase a2 in neurodegenerat ive disease

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted